Kazem Rahimi

Kazem Rahimi is a Professor of Cardiovascular Medicine and Population Health, at the University of Oxford and a consultant cardiologist at the Oxford University Hospitals NHS Trust. His research interests include hypertension, heart failure, multimorbidity and cardiovascular risk management, using a variety of methodologies such as individual-patient meta-analysis, large-scale decentralised clinical trials, and digital health technologies.



Kazem leads the Deep Medicine programme at the Nuffield Department of Women’s and Reproductive Health with a major interest in application of machine learning approaches to electronic health records. He also leads the Blood Pressure Lowering Treatment Trialists’ Collaboration (BPLTTC), which is an international collaboration of all the major trials of blood pressure lowering drugs. He is the Director of the Martin School programme on Informal Cities and a Co-Investigator of the PEAK-Urban programme.

Experience:

University of Oxford

Professor of Cardiovascular Medicine and Population Health

Nov 2020 – Present

Associate Professor of Cardiovascular Medicine

Jan 2014 – Oct 2020



British Cardiovascular Society

Programme Committee Member

Jun 2019 – Present



Deep Medicine programme, University of Oxford

Director, Deep Medicine programme

Sep 2016 – Present

Director, Informal Cities Programme

Sep 2019 – Present

James Martin Senior Fellow in Healthcare Innovation

Dec 2010 – Present



Nuffield Department of Women’s & Reproductive Health, University of Oxford

Member of the Senior Management Group and Chair of Research Strategy Group

Nov 2019 – Present



Oxford University Hospitals NHS Trust, Oxford Heart Centre

Honorary Consultant Cardiologist

May 2011 – Present



The George Institute for Global Health

Deputy Director

Apr 2011 – Apr 2020



SAPHIR Network

Member of the Board of Directors

Jan 2013 – Jan 2018



University of Oxford, CTSU

Clinical Research Fellow

2006 – 2009



King's College Hospital

Senior House Officer

2004 – 2006



University Heart center Leipzig

Assistenzarzt

2000 – 2004

Most cited publications:



Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013

Authors:  Naghavi, Mohsen; Wang, Haidong; Lozano, Rafael; ...  Murray, Christopher J. L.

Published:Jan 2015 in The Lancet

DOI: 10.1016/S0140-6736(14)61682-2



Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013

Authors:  Vos, Theo; Barber, Ryan M.; Bell, Brad; ...  Murray, Christopher J. L.

Published:Aug 2015 in The Lancet

DOI: 10.1016/S0140-6736(15)60692-4



Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer

Authors:  Darby, Sarah C.; Ewertz, Marianne; McGale, Paul; ...  Hall, Per

Published:Mar 2013 in New England Journal of Medicine

DOI: 10.1056/NEJMOA1209825



The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

Authors:  Baigent, Colin; Landray, Martin J.; Reith, Christina; ...  Collins, Rory

Published:Jun 2011 in The Lancet

DOI: 10.1016/S0140-6736(11)60739-3



Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition

Authors:  Murray, Christopher J. L.; Barber, Ryan M.; Foreman, Kyle J.; ...  Vos, Theo

Published:Nov 2015 in The Lancet

DOI: 10.1016/S0140-6736(15)61340-X